Recent Company News

• 10:10 PM ET Apr 15, 2026
  

  APAC morning themes include US-Iran in-principle ceasefire extension; Trend Micro-Anthropic AI security partnership (16-Apr)

• 11:08 PM ET Apr 13, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:13 AM ET Apr 13, 2026
  

  Transgene announces completion of patient randomization in the Phase 2 part of the Phase 1/2 clinical trial evaluating TG4050 (€0.78, 0.00)

• 01:39 AM ET Apr 13, 2026
  

  StreetAccount Themes APAC Headlines (13-Apr)

• 11:02 PM ET Apr 08, 2026
  

  APAC morning themes include Iran declaring Strait of Hormuz closed again; Cybersecurity slides on Anthropic Mythos hacking concerns (9-Apr)

• 11:48 AM ET Apr 02, 2026
  

  Transgene and NEC Bio sign license agreement to prepare next steps of the development of TG4050 (€0.74, 0.00)

• 07:36 PM ET Apr 01, 2026
  

  Morgan Stanley upgrades 4768.JP, 6701.JP; downgrades 2327.JP, 3923.JP

• 08:04 AM ET Mar 31, 2026
  

  DigitalBridge and JEXI complete acquisition of selected data center assets from NEC Corporation (¥3846.0000, 0)

• 11:40 PM ET Mar 29, 2026
  

  APAC morning themes include tech-heavy benchmarks seeing biggest losses; SoftBank sharply lower (30-Mar)

• 02:42 AM ET Mar 27, 2026
  

  NEC Corp completes up to 6.8M-share buyback (¥3990.0000, 0)